EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 66 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $470,477 | -0.7% | 49,008 | -29.7% | 0.06% | -44.9% |
| Q1 2020 | $474,014 | -54.4% | 69,708 | 0.0% | 0.12% | -35.5% |
| Q4 2019 | $1,038,649 | +45.4% | 69,708 | 0.0% | 0.18% | -17.6% |
| Q3 2019 | $714,507 | -3.3% | 69,708 | 0.0% | 0.22% | +7.2% |
| Q2 2019 | $738,905 | -24.2% | 69,708 | 0.0% | 0.21% | -27.1% |
| Q1 2019 | $974,518 | – | 69,708 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |